Novavax
NVAX
#5784
Rank
C$1.51 B
Marketcap
C$9.34
Share price
-1.59%
Change (1 day)
-21.71%
Change (1 year)

Novavax (NVAX) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : C$1.82 Billion

According to Novavax's latest financial reports the company's total liabilities are C$1.82 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Novavax - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31C$3.13 B-6.02%
2023-12-31C$3.33 B-15.04%
2022-12-31C$3.92 B5.18%
2021-12-31C$3.73 B206.4%
2020-12-31C$1.21 B159.8%
2019-12-31C$0.46 B-8.44%
2018-12-31C$0.51 B0.76%
2017-12-31C$0.50 B-5.42%
2016-12-31C$0.53 B314.86%
2015-12-31C$0.12 B140.62%
2014-12-31C$53.82 M58.56%
2013-12-31C$33.94 M54.44%
2012-12-31C$21.98 M69.79%
2011-12-31C$12.94 M-18%
2010-12-31C$15.78 M-4.14%
2009-12-31C$16.47 M-56.5%
2008-12-31C$37.85 M34.45%
2007-12-31C$28.15 M-13.24%
2006-12-31C$32.45 M-19.73%
2005-12-31C$40.43 M-24.71%
2004-12-31C$53.7 M-14.14%
2003-12-31C$62.54 M-19.89%
2002-12-31C$78.07 M23.69%
2001-12-31C$63.11 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Agenus
AGEN
C$0.70 B-61.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
C$2.97 B 62.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
C$1.20 B-34.27%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
C$1.14 B-37.58%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$93.62 B 5,023.97%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
C$158.08 B 8,551.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$85.49 B 4,578.95%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NanoViricides
NNVC
C$1.61 M-99.91%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
C$83.78 B 4,485.23%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
C$68.45 M-96.25%๐Ÿ‡บ๐Ÿ‡ธ USA